Ursprung des Netzwerks ersten Grades von Le Cong
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Rootpath Genomics, Inc.
Rootpath Genomics, Inc. BiotechnologyHealth Technology Rootpath Genomics, Inc. engages in the provision of biotechnology services. It develops personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy. The company was founded by Xi Chen, Le Cong, Yinqing Li, Cheryl Cui, and Ely Porter in 2017 and is headquartered in Cambridge, MA.
5
| Holding Company | Biotechnology | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Le Cong
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Connecticut Innovations, Inc.
Connecticut Innovations, Inc. Investment ManagersFinance Connecticut Innovations, Inc (CI) is venture capital firm founded in 1989. The firm is headquartered in Rocky Hill, Connecticut. | Investment Managers | Corporate Officer/Principal | |
SICOR, Inc.
SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
STANDARD BIOTOOLS INC. | Medical Specialties | Director/Board Member | |
PEAK Surgical, Inc.
PEAK Surgical, Inc. Medical SpecialtiesHealth Technology PEAK Surgical is a medical device company that has developed the PEAK Surgery System, a new tissue dissection system based on a proprietary technology that represents an important advance in radiofrequency surgical technologies. The PEAK Surgery System consists of the PEAK PlasmaBlade, a family of disposable cutting devices that offer the exacting control of a scalpel and the bleeding control of traditional electrosurgery without extensive collateral damage, and the PULSAR Generator, which supplies pulsed plasma radiofrequency energy to the PlasmaBlade. The PEAK Surgery System is cleared for use in general, plastic and reconstructive, ENT, gynecologic, orthopedic, arthroscopic, spinal and neurological surgical procedures in the United States, and for use in general surgery in the European Union. It was launched in the United States in July 2008 and has been used by U.S. surgeons on many patients, including general, gynecologic, orthopedic and plastic and reconstructive surgeries | Medical Specialties | Director/Board Member | |
NextWave Pharmaceuticals, Inc.
NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Ivenix, Inc.
Ivenix, Inc. Medical SpecialtiesHealth Technology Ivenix, Inc. operates as a medical device company. It develops and supplies infusion systems and intravenous-infusion pumps that eliminate air in the fluid bag line. The company was founded by John L. Bakos and Jeffrey Carlisle in 2007 and is headquartered in Amesbury, MA. | Medical Specialties | Director/Board Member | |
SV Health Investors LLC
SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Investment Managers | Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Doctorate Degree | |
The University of Texas at Austin | College/University | Graduate Degree | |
University of Toronto | College/University | Graduate Degree | |
Lehman Brothers Private Equity Group
Lehman Brothers Private Equity Group Investment ManagersFinance Lehman Brothers Private Equity Group operates as a private equity firm. The company was founded in 1984 and is headquartered in New York, NY. | Investment Managers | Corporate Officer/Principal | |
Shanghai Jiao Tong University | College/University | Undergraduate Degree | |
Imagen Biotech, Inc.
Imagen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Imagen Biotech, Inc. develops therapeutics for sight-threatening diseases. The firm specializes in personalized chemotherapy, medicine, high content screening, cell biology and contract research. The company was founded by David R. Guyer and Matthew Feinsod in 2011 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
TAURIGA SCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin | |
Yale School of Medicine | College/University | Doctorate Degree | |
Impresa Management LLC
Impresa Management LLC Investment ManagersFinance Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston. | Investment Managers | Private Equity Investor | |
LifeMine Therapeutics, Inc.
LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder | |
Nest.Bio Ventures
Nest.Bio Ventures Investment ManagersFinance Nest.Bio Ventures (Nest.Bio) is a venture capital firm founded in 2017. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Founder | |
HiFiBiO Inc.
HiFiBiO Inc. Pharmaceuticals: MajorHealth Technology HiFiBiO Inc. develops and manufactures pharmaceutical products. It specializes in antibodies, that mobilize the human immune system to combat cancer, autoimmune disorders, and other unmet medical needs. The company was founded by Liang Schweizer, Fred Dom, Andrew Griffiths, David Weitz, Bradley Bernstein, J?r?me Bibette, and Robert Nicol and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member | |
WuXi Healthcare Ventures Management US LLC | Consultant / Advisor | ||
Hangzhou Bota Biosciences Co., Ltd.
Hangzhou Bota Biosciences Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Hangzhou Bota Biosciences Co., Ltd. is a company that provides biotechnology development and technical consulting services. Hangzhou Bota Biosciences Co., Ltd. is based in Hangzhou, China and was founded in 2019. | Miscellaneous Commercial Services | Chairman | |
Bota Biosciences, Inc. | Chief Executive Officer |
Statistik
International
Vereinigte Staaten | 25 |
Kanada | 3 |
China | 3 |
Sektoral
Health Technology | 11 |
Finance | 9 |
Consumer Services | 6 |
Commercial Services | 3 |
Distribution Services | 2 |
Operativ
Director/Board Member | 12 |
Founder | 7 |
Corporate Officer/Principal | 6 |
Private Equity Investor | 5 |
Chief Executive Officer | 3 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Hingge Hsu | 22 |
Cheryl Cui | 7 |
Xi Chen | 4 |
Ely Porter | 1 |
Yinquing Li | 1 |